Intelligence · Clinical Development
Pipeline search results
Programs matching “autologous” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "autologous" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)
LISATA THERAPEUTICS, INC.
Stage IV Melanoma
1 trial -
Autologous Peripheral Blood Stem Cell injection
Hospital Authority, Hong Kong
Acute Myocardial Infarction
1 trial -
Expanded autologous adipose-derived adult stem cells (eASCs)
Takeda
Complex Perianal Fistula
1 trial -
Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)
Disc Medicine
Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)
1 trial -
Suspension of autologous mononuclear cells separated from bone marrow aspirate
The George Institute
diabetic foot syndrome, lower limb ischemia
1 trial -
eythrocytapheresis
Atrium Therapeutics
Pre Operative Autologous Donation
1 trial -
Autologous (self) mononuclear cells derived from umbilical cord blood
Regeneron Ireland Designated Activity Company (DAC)
Hypoplastic Left Heart Syndrome
1 trial -
Autologous BCMA-targeting CAR T cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma in Relapse
1 trial -
Autologous Bone Marrow Mononuclear Cells
Lxo Ireland Designated Activity Company
Peripheral Vascular Diseases
1 trial -
Autologous CD5 CAR T-cells
Universal Integrated
T-Cell Acute Lymphocytic Leukemia
1 trial -
Autologous CD5 CAR T-cells
The First People's Hospital of Lianyungang
T-Cell Acute Lymphocytic Leukemia
1 trial -
Autologous CD7 CAR T-cell
Universal Integrated
T-cell Acute Lymphoblastic Leukemia
1 trial -
Autologous Fat Transfer
United Therapeutics Europe Ltd
Wound
1 trial -
Autologous Room Temperature stored Platelet transfusion
United Therapeutics Europe Ltd
Reversal of Platelet Aggregation Inhibitors
1 trial -
Autologous Skin Fibroblasts
United Therapeutics Europe Ltd
Amputation
1 trial -
Autologous Tumor Infiltrating Lymphocytes MDA-TIL
Iovance Biotherapeutics B.V.
Malignant Solid Neoplasm
1 trial -
Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees
United Therapeutics Europe Ltd
Amputation
1 trial -
Autologous adipose derived mesenchymal stem cells
Lxo Ireland Designated Activity Company
Critical Limb Ischemia (CLI)
1 trial -
Autologous bone marrow mononuclear cell transplantation
EuroGen Pharmaceuticals Ltd
Spinal Cord Injury
1 trial -
Autologous hematopoietic stem cell infusion
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prolonged Cytopenia Following CAR-T Therapy
1 trial -
Autologous mesenchymal stem cells from adipose tissue.
Lxo Ireland Designated Activity Company
Autoimmune Diseases
1 trial -
Bone marrow mesenchymal stem cells autologous
Lxo Ireland Designated Activity Company
Multiple Sclerosis
1 trial -
CCM-RNT-202402
Kyverna Therapeutics
ANCA-IgG-positive ANCA Associated Vasculitis
1 trial -
FIB-BIO-2023-03
Lxo Ireland Designated Activity Company
Cleft Lip and Palate
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.